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Despite advances in themanagement of HIV infection with the introduction of combination
antiretroviral therapy, it is well known that HIV can directly infect the central nervous
system and, as a result of such infection, neuropsychological impairments can be
manifested. In this study, we tried to determine whether seropositivity was associated
with a poor neuropsychological performance in patients with hemophilia and HIV. Such a
cohort of patients is very often underrepresented and understudied in the HIV literature. To
amend such a gap, we carried out an extensive neuropsychological evaluation on these
patients, and compared their performance with that of a group of seronegative hemophilia
patients. The results revealed that HIV infection in HIV-seropositive (HIV+) hemophilia
patients was associated with deficits in attention, short-term memory, abstraction, and
visual recognition. Such results are still preliminary and explorative due to the small
cohort of patients enrolled. However, the results do seem to have some important
implications for day-to-day functioning, as the level of impairment detected may cause
difficulties in completing common everyday tasks such as maintaining adherence to
complex medication regimens or maintaining social life activities. Continued research
into the mechanisms related to HIV and neurocognitive dysfunction may provide targets
for interventions that could have meaningful consequences in the real world for HIV
hemophilia patients.
Keywords: hemophilia, HIV, neuropsychological impairments, cognitive disorders, neuropsychological
assessment
Introduction
Although severe forms of HIV-associated neuropsychological impairments have decreased since
the widespread use of combination antiretroviral therapy (cART), such impairments continue
to persevere among patients with HIV infection (Heaton et al., 2010; Becker et al., 2011; Grant
et al., 2014). Different elements contribute to the development and severity of neuropsychological
impairments, such as potentially irreversible brain injury that occurred before patients were started
on cART, as well as imperfect blood–brain barrier penetrance leading to inadequate suppression of
the adverse effects of HIV on central nervous system (CNS) function [for review, see Heaton et al.
(2011)]. In addition, there is a high prevalence of comorbid conditions and confounding factors
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that may interfere with the effects of HIV on the CNS (Weiss et al.,
2010), such as CD4 nadir count (Munoz-Moreno et al., 2008; Ellis
et al., 2011; Heaton et al., 2011), the time of infection (Ettenhofer
et al., 2009), the presence of other infections such as hepatitis C
virus, and the use of drugs (Clifford et al., 2005; Shimizu et al.,
2011).
Current estimates indicate that as many as 50% of HIV+ indi-
viduals display some degree of neuropsychological impairment
(Dawes et al., 2008; Giesbrecht et al., 2014) when impairment is
derived from comparisonswith normative performance standards
(e.g., Heaton et al., 2011; Giesbrecht et al., 2014). Nevertheless, a
recent meta-analysis revealed lesser attentional, motor, and exec-
utive skill impairments in HIV+ individuals treated with cART
(Al-Khindi et al., 2011). Although neuropsychological profiles
vary among HIV+ individuals (Giesbrecht et al., 2014), deficits
in speed of information processing (Llorente et al., 1998; Carey
et al., 2004, 2006; Giesbrecht et al., 2014), fine motor speed and
dexterity (Chang et al., 2002; Judd et al., 2005), aspects of learning
and memory (Peavy et al., 1994; Carey et al., 2006; Martin et al.,
2007; Maki et al., 2009), especially verbal memory (Seider et al.,
2014) and prospective memory (Doyle et al., 2013), abstraction
(Heaton et al., 1995), and attention (Heaton et al., 1995; Hardy
and Hinkin, 2002; Levine et al., 2008). Multiple domains of exec-
utive functioning, such as cognitive flexibility, decision-making,
and planning (Chang et al., 2002; Iudicello et al., 2008; Munoz-
Moreno et al., 2008; Cattie et al., 2012), have also been commonly
identified and described.
Despite significant advances in our knowledge over the past
20 years regarding the prevalence, clinical correlates, and func-
tional impact ofHIV-associated neuropsychological impairments,
we still know very little about the different types of neuropsy-
chological profiles, which are HIV-associated in different popula-
tions. A limitation of the existing literature examining cognitive
disorders in HIV is the underrepresentation of certain types of
infected populations with HIV. Neuropsychological impairments
have been mainly studied in HIV-seropositive (HIV+) patients
infected vertically or postnatally during the earliest period of life
of the child (e.g., through breast milk) or in specific cohorts of
adults such as drug users. Both such macro-categories present
confounding factors that may also affect cognitive performance,
therefore making it difficult to identify the cognitive impairments
attributable to HIV infection. Indeed, it has been shown that
children infected vertically or immediately postnatally present
adjunctive disorders (Isanaka et al., 2009; Siegfried et al., 2011),
such as HIV-related dysfunctions in energy balance (Henderson
et al., 1994; Mulligan et al., 1997; Johann-Liang et al., 2000;
Batterham, 2005), neuro-developmental growth changes (Ron-
danelli et al., 2002; Van Rossum et al., 2003), and neurological
changes (Reger et al., 2002; Heaton et al., 2004; Antinori et al.,
2007). In the cohort of drug users, patients show different neu-
ropsychological impairments; however, these profiles are often
difficult to describe because they are complicated by a myriad
of confounding factors such as the abuse of substances as alco-
hol, cocaine, and opiates (Starace et al., 1998; Lundqvist, 2010;
Buttner, 2011), emotional disorders, such as anxiety and depres-
sion (Byrd et al., 2013), and different risk behaviors (De Ronchi
et al., 2002).
While cognitive disorders in HIV are prolific in these areas
of research, they remain comparatively understudied in other
cohorts of patients, for example, patients who were medically
induced with HIV infection through blood transfusions. Such
patients represent an interesting cohort because they were gener-
ally infected postnatally at an older age, and because they generally
do not present the confounding factors of drug-user popula-
tions (Rubin et al., 1999; Brown et al., 2000; Ettenhofer et al.,
2009). Among these patients, those with hemophilia represent a
particularly interesting cohort of patients (Riva et al., 2014a).
Hemophilia
Hemophilia is a rare coagulation disorder in which a crucial
clotting factor in blood is missing either partly or completely.
Being a sex chromosome-gene-related bleeding disorder, it occurs
primarily in the male population (White et al., 2001). The clinical
hallmark of hemophilia is recurrent spontaneous bleeding, most
frequently in joints such as the ankles, elbows, and knees, as
well as in muscles (Kern et al., 2004; Muça-Perja et al., 2012;
Gringeri et al., 2013). The treatment of hemophilia is based on the
replacement of the missing clotting factor when bleeding occurs
(on-demand treatment) or on a regular and continuous basis
(prophylactic treatment) (Santagostino and Mannucci, 2000). In
the western world, prophylactic treatment of young hemophiliac
patients is considered as current best practice (Krasuska et al.,
2012; Santoro et al., 2013; Franchini et al., 2014). Generally, pro-
phylaxiswith clotting factors is initiated in childhood after the first
joint bleed by the age of 2–4 years (Santagostino and Mannucci,
2000; Makris, 2012; Richards et al., 2012). One of the greatest
risks faced by those with hemophilia in the late 1970s and early
1980s was the possibility of contracting HIV, commonly known
as the AIDS virus (Franchini and Mannucci, 2012; Mangiafico
et al., 2012). This happened when people received transfusions
of clotting factors drawn from infected blood. It is estimated
that 60–70% of people with hemophilia were infected with HIV
in this way between 1979 and 1985 (Mannucci, 2005). In those
years, blood donations were not tested for HIV and people with
hemophilia were especially likely to get infected for two reasons:
they received many transfusions, and each transfusion contained
pooled clotting factors drawn from the blood of numerous donors
in order to obtain enough clotting factors to be effective. If any
one of those donors happened to be infected with HIV, then the
hemophiliac was at risk.
For this reason, the cohort of patients who have both
hemophilia and HIV represents a different and interesting cohort
of HIV patients to be evaluated in relation to neuropsychological
impairments.
However, studies on HIV+ hemophiliacs and neuropsycho-
logical impairments are sparse and not very recent. The most
important investigation in this field was the Hemophilia Growth
and Development Study (HGDS) by Hilgartner et al. (1993). The
HGDS was a multicenter study of the long-term effects of HIV
infection on growth andneurodevelopment inHIV+hemophiliac
children and adolescents most of whom were asymptomatic for
HIV disease at baseline, in comparison to a group of HIV 
hemophiliacs of similar age. Longitudinal and prospective data
from the HGDS identified some specific impairments at the
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memory level (Loveland et al., 2000; Nichols et al., 2000), attention
(Watkins et al., 2000), and language. These impairments, however,
were not clearly described in relation to HIV infection but as neu-
ropsychological impairments related to socio-educational covari-
ates such as school absenteeism and poorer academic achieve-
ment, which frequently marked these young patients.
The other few studies have identified cognitive impairment
in HIV+ hemophiliacs as related to the decrease in immuno-
logical functioning, especially when the CD4+ cell count is
lower than 200. For example, Riedel et al. (1992) identified
a linear association between neuropsychological impairment in
attention, motor skills, visual performance, and the decrease
of CD4+. Similarly, Blanchette et al. (2002) identified impair-
ments in motor speed and fine motor skills, and Nichols et al.
(2000) concluded that HIV+ hemophiliacs presented deficits in
communication skills in relation to their immune-functioning
system.
Although there are some studies available in the context of
a pediatric population, studies are totally underrepresented in
the adult population with mixed and confusing results (Turnbull
et al., 1991; Riedel et al., 1992). The only two exceptions are the
work of Siboni et al. (2009) and Zanon et al. (2014). The first
work compared the Mini-Mental State Examination (MMSE) in
a hemophiliac HIV  population with the general population,
in which differences were not found to be significant. Similarly,
the second work determined that HIV  adult hemophiliacs pre-
sented a normal overall cognitive performance as measured by
the MMSE >25 (Folstein et al., 1975). Alterations occurred only
in some patients and they were associated with the presence of
spontaneous brain hemorrhage (microbleeds).
However, no prospective studies about adults HIV+ hemophil-
iacs are currently available.
Therefore, understanding the temporal course and the mech-
anisms of cognitive impairment in this cohort of patients repre-
sents an important goal of current research in order to broaden
and deepen our current understanding of the impact of HIV on
postnatal growth.
Considering the lack of research consensus about the type of
neuropsychological impairments and the scarcity of research in
the context of hemophilia, the present study aimed to assess the
presence and the extent of neuropsychological impairments in a
randomly selected cohort of HIV+ adult hemophiliacs compar-
ing the performance of this cohort with that of a control group
composed of HIV  hemophiliacs.
Materials and Methods
Participants
Fifteen HIV+ hemophiliacs (experimental group) and 30 HIV 
hemophiliacs (control group) were administered neurocognitive
batteries between December 2012 and December 2013. Consec-
utive patients were recruited through their treating physicians
via the hemophilia and thrombosis outpatient clinics for three
Italian centers. All hemophiliacs had adequate Italian language
fluency for the purpose of valid psychometric testing. The inclu-
sion criteria for the experimental group were as follows: diagnosis
of hemophilia, diagnosis of HIV with CD4+ counts consistently
TABLE 1 | Participants characteristics.
HIV-group
(n= 30)
HIV+ group
(n= 15)
Sig.
n % n %
Highest educational attainment 0.060a
Primary school 3 10 1 7
Secondary school 3 10 8 53
High school 18 60 5 33
University 6 20 1 7
Currently in professional occupation 0.255b
Yes 23 77 9 54
No (unemployed/disability pension) 7 23 6 46
M SD M SD
Age 44 8.9 45 8.4 0.446a
aMann–Whitney U test.
bChi-square test.
>200 cells/mm3, treatment with cART, age >18 years. Exclusion
criteria included diagnosis of AIDS, serious mental illness with
a certificated diagnosis (e.g., major depression, anxiety, bipo-
lar disorder), or known CNS pathology, including progressive
multifocal leukoencephalopathy, cancer affecting the brain, neu-
rosyphilis, active cytomegalovirus infection, multiple sclerosis,
stroke, and seizures/epilepsy. Control patients had a diagnosis of
hemophilia and were tested for HIV antibody upon recruitment
to the study unless they had a negative test in the past 3months
with no other illness during this time period.
Neurocognitive assessment was conducted by the first author
(Silvia Riva) in Milan and Naples and by Silvia Riva and Ilaria
Cutica (co-authors) in Rome. Table 1 summarizes the patients
enrolled in the three hospitals.
Ethics Statement
Written informed consent was obtained from each patient. The
study was approved by the institutional ethical committees of the
three Italian centers involved in this study: the IRCCS Ca’Granda
(Milan), The Umberto I Hospital (Milan), and the S. Giovanni
Bosco Hospital (Naples) (reference number of IRCCs Ca’Granda,
coordinator center: 18092012). The studywas conducted in accor-
dance with the Helsinki Declaration (59thWMAGeneral Assem-
bly, Seoul, 2008).
Neuropsychological Assessment
Patients completed an extensive neuropsychological test bat-
tery measuring five major cognitive domains. Attention (1) was
assessed by the Trail Making Test (TMT), which is a neuropsy-
chological test of visual attention and task switching (Tombaugh
Nichols et al., 2000). Memory (2) was assessed by the Let-
ter–Number Sequencing of the Weschler Adult Intelligence Scale,
third edition (WAIS-III) (Wechsler, 1995), which measures the
number storage capacity of the working memory (Digit span
memory). Language Comprehension (3) was assessed with the
short version of the Token Test, which is a valuable measure for
assessing receptive language (Spellacy and Spreen, 1969). Visual
recognition (4) was assessed by the Rey Tangled Lines Task (Rey,
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1964), a visual tracking and visuomotor processing task. Finally,
executive functions (5) were assessed widely by the Clock-drawing
Test (Freedman et al., 1994), which is a widespread test used for
screening cognitive impairments and dementia andmeasures spa-
tial dysfunctions and neglect, by the Verbal Fluency test (Lezak,
1995) designed to test phonemic memory in which participants
have to say as many words as possible from a category in a
given time (60 s), and by the Italian Test of abstraction of the
Brief Neuropsychological Exam (Mondini et al., 2003) aimed at
detecting the ability of logical reasoning and generalization of
concepts.
Procedure
After pre-selection of patients, patients were asked to give their
written consent to data collection by signing the data protec-
tion form. Neuropsychological profiles were based on neuropsy-
chological assessment and recorded by means of documentation
forms that were completed by the research psychologist (Silvia
Riva). Patient status (HIV+ or HIV ) was blinded to the exam-
iner. The examiner was not blinded only for the data analysis
phase.
Overall patient clinical status was evaluated at routine medical
appointments, including presence of concomitant diseases and the
monitoring of safety variables (e.g., adverse events).
Sample Size Determination
The optimal sample size was calculated through analyzing and
integrating related publications on cross-sectional studies (Riedel
et al., 1992; Blanchette et al., 2002) via effect sizes (F-values
respective η-square-values, Cohen’s d, and Λ for multivariate
approaches) with G*Power (Faul et al., 2007). A synopsis of
needed sample sizes for the different articles and different out-
comemeasures within the articles was constructed and evaluated.
This resulted in an approximate value of the minimum total sam-
ple size of 10 cases and 20 controls with a case-control ratio of 1:2.
There were two essential reasons for considering the 1:2 matching
scheme: (1) concern for sufficient numbers in stratified analysis;
(2) increasing power given the expected prevalence (Hennessy
et al., 1999). Overall, we enrolled 45 patients: 15 cases and 30
controls.
The sample size calculation took into account the prevalence
of hemophilia as a rare disease (10 per 100,000 males born)
and the incidence of HIV (currently, around 70% of diagnosed
hemophiliac patients are HIV+ because of receiving infected
blood products prior to the availability ofHIV screening) (Clinical
and Epidemiological Key Elsevier, 2014).
In order to avoid bias in the inclusion phase, we collected a
complete list of the patients, and chose patients via the use of a
random number generator. HIV  hemophiliacs were matched
with HIV patients by age (5 years).
Statistical Analysis
All comparisons made between HIV+ and HIV  groups were
conducted on raw cognitive data. For conventional neurocogni-
tivemeasures (TrailMakingTest, Digit Span, Verbal Fluency Test),
performance of the HIV+ group was further inspected in the
context of published normative data using the following proce-
dures. First, each HIV+ participant’s raw score was converted to
its corresponding age-corrected standard score based upon the
published norm-referenced data.
Given the relatively small number of participants, the non-
normality of several distributions and the unbalanced groups, we
decided to use the exact methods with Monte–Carlo approxima-
tion: a series of non-parametric statistical algorithms that enable
researchers to make reliable inferences when data are sparse,
heavily tied or unbalanced, not normally distributed, or fail to
meet any of the underlying assumptions necessary for reliable
results using the standard asymptotic method (Siegel and Castel-
lan, 1988). The exact methods with Monte–Carlo approximation
used for comparisons were the Wilcoxon–Mann–Whitney Test
for continuous measures, and Chi-square for categorical variables
(α= 0.05, two-tailed).
Finally, one-way ANCOVAs were conducted to compare the
scores between the two groups on raw data of neuropsychological
measures that were obtained in both groups, co-varying for age,
education, and working status.
Results
Patients Characteristics
HIV+ and HIV  hemophiliac patients were matched on age;
however, no significant differences were found for other socio-
demographic variables, such as education, and working status.
It is worth noting the frequency of patients with disability pen-
sion or unemployed (higher percentage in the HIV+ group)
and the smaller presence of patients with a high level of school-
ing (particularly in the HIV+ group). Details are presented in
Table 1.
Neuropsychological Assessment Results
Scores on the cognitive domains and on each individual test
(raw test scores SD for tests) of the two groups are shown in
Table 2. Subsequent analyses of the individual domains showed
a significantly worse performance of HIV+ hemophiliacs on the
domains Attention (Trail Making A test, U= 104.50, z= 2.80,
p= 0.005; Trail Making B test, U= 107.00, z= 2,73, p= 0.006),
Memory (Digit Span memory, U= 141.00, z= 2.06, p= 0.039),
and Abstraction (U= 144.00, z= 2.06, p= 0.039), and Visual
recognition (U= 115,00, z= 2.56, p= 0.010).
HIV+ Patients’ Neuropsychological Impairments
Relative to Normative-Referenced Standards
When the HIV+ hemophilia patients’ neuropsychological perfor-
mances were indexed in accordance with published normative-
referenced standards, the magnitude of impairments appeared
comparable to data estimated on raw scores in relation to Exec-
utive functions (Phonemic memory) (U = 217.00, z= 0.013,
p= 0.990) and to Attention (Trail Making A: U = 110.00,
z= 2.79, p= 0.005; Trail Making B: U= 150.00, z= 2.10,
p= 0.005).
The only exception was for the task ofMemory, where the mag-
nitude of impairment was not significant (U= 183.00, z= 1.68,
p= 0.286).
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TABLE 2 | Neuropsychological test results on the different cognitive
domains and on each test for the HIV  and the HIV+ hemophiliac groups.
Cognitive domains HIV-group
(n= 30)
HIV+ group
(n= 15)
p-Value r (Z/pN)*
Mean (SD) Mean (SD)
Attention
Trail Making Test A 40:38 (12:91) 60:93 (24:52) 0.005 0.45
Trail Making Test B 128:66 (57:38) 173:53 (63:39) 0.002 0.47
Memory
Digit span memory 4:90 (1:34) 3:93 (1:71) 0.039 0.34
Phonemic memory 31:45 (6:13) 27:53 (6:20) 0.619 0.01
Abstraction
Test of abstraction 5:13 (1:19) 4:40 (1:29) 0.39 0.34
Language
Token Test 4:97 (0:18) 4:73 (0:79) 0.131 0.03
Visual recognition
Rey Tangled Lines Task 3:54 (0:83) 2:67 (1:17) 0.008 0.39
Executive function
Clock-drawing Test 7:27 (1:80) 6:77 (1:20) 0.340 0.02
Test scores are presented as mean raw test scoresSD.
Mann–Whitney U test with Monte–Carlo p estimation between groups.
*r= effect size. Small size=0.1; medium size=0.3; large size=0.5.
ANCOVA and Interactions
In addition to analyzing overall neuropsychological impairment,
we were interested to determine whether any specific areas of neu-
ropsychological performance were impacted by the interaction of
age, educational level, and working status. This was accomplished
by ANCOVA, controlling for the effect of age, education, and
working status.
The analysis controlled for age and education and working
status revealed that the HIV+ hemophiliac group performed
worse than theHIV  hemophiliac group onAttentionwith regard
to the Trail Making A Test (F= 12.379, p= 0.001), on Executive
Functions with the test of Abstraction (F= 5.274, p= 0.027) and
Visual recognition (F= 5.583, p= 0.022).
However, the predicted main effect of age was not significant
(F= 2.00, p= 0.16, η2p = 0:003), neither was the predicted main
effect of education (F= 3.25, p= 0.072, η2p = 0:004), and nor was
the predicted main effect of working status (F= 3.33, p= 0.081,
η
2
p = 0:008). The interaction among age, education, and working
status was also not significant (F= 0.016, p= 0.90, η2p = 0:001).
Although the introduction of covariates reduced the distance
between the two groups of hemophiliacs (HIV+ and HIV ),
they did not eliminate the effect of HIV infection on neuropsy-
chological impairment completely. Therefore, the presence of
these covariates (age, educational level, and working status), even
though they did have an impact, did not explain group differences
per se.
Discussion
Although neuropsychological impairments are well-described in
some specific HIV populations, very few studies have investigated
the cohort of patients with hemophilia and HIV. In addition, they
have often yielded inconsistent results, mainly due to method-
ological differences. Furthermore, only a few such studies were
performed in the cART era.
Moreover, as most of them were conducted on pediatric pop-
ulations and not on adults, the generalizability of their findings
is highly impaired. All these factors limit the generalizability of
findings across this relatively small body of work.
By contrast, our current pilot study carefully defined and inves-
tigated cognitive disorders using standardized clinical tasks in
a defined, well-characterized cohort of patients with HIV. This
pilot examination revealed that in a small but well-controlled
sample, it was possible to detect some signals of neuropsycho-
logical impairment in the context of hemophilia patients with
HIV. More specifically, the results of this study showed a worse
performance on neuropsychological assessment in our sample of
HIV+ hemophiliacs compared with the control group of HIV 
hemophiliacs, when combining all tests in one overall analysis.
The HIV+ hemophiliacs had significantly lower scores on tests
of attention, memory, executive function (abstraction test), and
visual recognition than did the control group. However, when
adjusted for age, education, and working status, the real distance
between the two groups reduced, and the difference on memory
revealed to be not significant. The observation of anHIV effect on
tests requiring rapid processing of information (attention) is con-
sistent with the classic conceptualization of HIV as a subcortical
disease targeting frontal–striatal circuits supporting these abilities
(Reger et al., 2002; Baldewicz et al., 2004).
The finding of a decline in abstraction function is unique in
the cohort of HIV+ hemophilia patients even though it has been
observed in the general HIV population (Heaton et al., 1995).
Impairments in language were not found in our study. The
absence of language disorders appears to contrast slightly with
the main research on cognitive disorders in hemophilia, namely
that conducted in the HGDS. Indeed, in the HGDS, the authors
found the presence of language disorder in HIV+ pediatric
patients but concluded that this disorder was associated with
socio-educational factors, since these patients were more exposed
to school absenteeism and lower school participation due to
the management of their physical conditions requiring frequent
medical examinations. However, our results cannot be completely
compared with those of the HGDS as our sample was composed
of adult patients and not of children or adolescents.
Regarding the ANCOVA analysis, we found a correlation
between cognitive disorders and socio-demographic factors (age,
education, and working status) as reported in the HIV literature.
Even this result is innovative in the field of hemophilia and
HIV in the adult population, especially regarding working status.
However, these differences cannot be totally attributable to these
covariates and it is reasonable to attribute a weight to the HIV
infection.
Future comprehensive studies, however, are expected to explore
the above-mentioned relationship and to clarify more concisely
the weight of each confounding factor, not only cross-sectionally
but also longitudinally.
Taken together, these findings, while preliminary, highlight
important considerations for the design of clinical research studies
exploring the cognitive effects of HIV in hemophiliacs. The cur-
rent study adds to the growing literature on HIV+ hemophiliacs
and cognition in the cART era and was strengthened by selective
inclusion criteria (such as the level of CD4>200, the absence of a
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psychiatric disorder, such as a diagnosis of depression/anxiety),
thereby allowing the evaluation of a precise and representative
cohort. Previous studies either lacked a matched control group
or examined cognition in isolation. One of the main strengths of
the current study is that it is one of the few to examine cognitive
impairments in the cohort of hemophilia patients in adulthood
and provides an update to reference studies, which are not very
recent in this field. Also, studies in European samples of HIV
patients are very scarce. This study represents one of the firsts
European cohort study in hemophilia withHIV patients exploring
the level of cognitive impairments.
Another strength is that this study provides an overview
of the social situation of these patients who live with another
chronic condition, hardly ever reported in the literature. Patients
with HIV+ hemophilia present a higher rate of unemployment
status, and a lower level of schooling, which probably leads
to more difficulties in finding a job (Chernoff et al., 2010).
Rates of unemployment in HIV+ hemophiliacs in this study
were comparable to those in chronic illnesses with a recognized
disability such as rheumatoid arthritis (Wallenius et al., 2009) but
lower than those in other disabling conditions such as multiple
sclerosis (Khan et al., 2009). This scenariomust also be considered
seriously from a social and health policy perspective. A multidis-
ciplinary approach is likely to be needed, addressing both physical
and psychological barriers to working, including overcoming
perceived barriers to work, increasing confidence and motivation
to work, and facilitating skills training and work placement
(Kielhofner et al., 2004). The potential for the doctor–patient
relationship (Riva et al., 2012; Riva et al., 2014b) in HIV to help
promote a return to employment should be considered, with
discussion forming a part of the routine HIV consultation.
As with all research, several limitations should be noted. The
current study was not designed to longitudinally track the effects
HIV on cognitive functioning. Future longitudinal studies may
investigate more, in-depth, the presence of cognitive impairment
in this population and the relationship with antiretroviral med-
ications in order to evaluate whether and how the value of long-
term treatment versus short-term treatment impacts differently on
cognitive impairment. Moreover, this study was not additionally
designed to compareHIV hemophiliacs with a parallel sample of
the Italian general population because, as shownby the existing lit-
erature, the cohort of HIV  hemophiliacs seems not to show any
evident cognitive decline compared with the normal population
(Siboni et al., 2009). However, a comparison with a specific sub-
group from the general population would have further enhanced
the study.
This study is limited by its design as a pilot and suffers from
methodological challenges, such as the potential instability of
the data related to the small sample size. However, the presence
of statistically significant results renders the findings even more
provocative. Future studies, with larger samples, should be com-
pleted to replicate these findings and to test for potential interac-
tion effects among variables of interest. Another limitation is the
lack of data on MRI abnormalities and other neurological indi-
cators, which made it impossible to link the neuropsychological
assessment results with some neurobiological correlates or other
medical observations.
In conclusion, this cross-sectional pilot study showed decre-
ments in the neuropsychological profile, specifically in attention,
memory, executive function (abstraction test), and visual recog-
nition in a small, but representative, randomly selected sample
of hemophilia patients with HIV+ in comparison with the con-
trol group of HIV  hemophilia patients. The findings of the
current study indicate that future research should focus on fur-
ther unraveling the underlying mechanism of neuropsychological
impairments, using neuropsychological tests, in combinationwith
neuroimaging techniques in a larger sample.
Finally, the neuropsychological impairments detected in this
study have important implications for day-to-day functioning.
The level of impairment detected may cause some problems in
completing common everyday tasks such as maintaining adher-
ence to complex medication regimens (both for hemophilia and
HIV), as well as holding down a full-time job. These impair-
ments, in combination with hemophilia, may make some activ-
ities of self-care more cumbersome. As recently pointed out by
the work of Fazeli et al. (2014) on HIV patients with associated
neurocognitive disorders, working and active engagement in life
tend to strengthen neurocognitive functioning, “by enhancing
cognitive and/or brain reserve” (p. 234). Continued research into
the mechanisms related to HIV and neurocognitive dysfunction
may provide targets for interventions that could have meaningful
consequences in the real world.
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